Abstract
Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have